"The voice for cancer physicians and their patients in Massachusetts."
FDA) approved zanubrutinib (Brukinsa, BeiGene USA, Inc.) for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Read More.
View full prescribing information for Brukinsa.
Massachusetts Society of Clinical Oncologists ©2023
860 Winter Street, Waltham, MA, 02451
Tel: 781.434.7329 | email: email@example.com